JUSTIN PENTENRIEDER

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.Con.Res. 8 FY14 Senate Budget Resolution, H.R. 993 Consolidated & Further Continuing Appropriations Act of 2013. H.J.Res.117, the Continuing AppropriationsResolution Act; and the President's FY14 Budget.

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.Con.Res. 8 FY14 Senate Budget Resolution, H.R. 993 Consolidated & Further Continuing Appropriations Act of 2013. H.J.Res.117, the Continuing AppropriationsResolution Act; and the President's FY14 Budget.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.Con.Res. 8 FY14 Senate Budget Resolution, H.J.Res.117, the Continuing Appropriations Resolution Act; the President's FY14 Budget; and S.1284, the FY14 Labor,Health & Human Resources Appropriations Act.

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. The President's FY14 Budget; and S.1284, the FY14 Labor, Health & Human Resources Appropriations Act, and matters relating to the impact of the government-widesequester as it affects CDC, NIH, NCI, Prevention & Public Health Fund, and other appropriated accounts relating to cancer.

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.Con.Res. 8 FY14 Senate Budget Resolution, H.J.Res.117, the Continuing Appropriations Resolution Act; the President's FY14 Budget; and S.1284, the FY14 Labor,Health & Human Resources Appropriations Act.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act; S. 621 and H.R. 1285, the Safe Prescribing Act;H.R. 1366, the Stop Oxy Abuse Act; and issues relating to tanning beds before the FDA, HHS and the House and Senate.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress; the Sun Act, the Family Act, Health Equity and Accountability Act, the Clean Cookstoves Support Act, and the Patient Centered Quality of Care Act. Also, H.R.1339 & S. 641, the Palliative Care and Hospice Education and Training Act and H.R. 1070, Reducing Barriersto Colorectal Cancer Screening Act and S. 621 and H.R. 1285, the Safe Prescribing Act and H.R. 1366, the Stop Oxy Abuse Act.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S. 39, Healthy Lifestyles and Prevention America Act,H.R. 792 & S. 772, cigar exemption from FDA regulations; S. 194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership.

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; and H.R.1666, the Patient Centered Quality Care For Life Act. Also, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act;S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act.

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.Con.Res. 8 FY14 Senate Budget Resolution, H.J.Res.117, the Continuing Appropriations Resolution Act; the President's FY14 Budget; and S.1284, the FY14 Labor,Health & Human Resources Appropriations Act.

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.Con.Res. 8 FY14 Senate Budget Resolution, H.J.Res.117, the Continuing Appropriations Resolution Act; the President's FY14 Budget; and S.1284, the FY14 Labor,Health & Human Resources Appropriations Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC); and (4) issues relating to NIH reorganization. Legislation includes H.R.3186 and S.1706, Smuggled Tobacco Prevention Act; H.R.3382, Smoke-Free Federal Building Act; S.1403, IDEA Full Funding Act; and H.R.65: Candy Tobacco Tax Parity Act of 2011. Issues related to cigar regulation on H.R.5973. Issues relating to tobacco and trade, including the Trans-Pacific Partnership.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC); and (4) issues relating to NIH reorganization. Legislation includes H.R.3186 and S.1706, Smuggled Tobacco Prevention Act; H.R.3382, Smoke-Free Federal Building Act; S.1403, IDEA Full Funding Act; and H.R.65: Candy Tobacco Tax Parity Act of 2011. Issues related to cigar regulation on H.R.5973. Issues relating to tobacco and trade, including the Trans-Pacific Partnership.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC); and (4) issues relating to NIH reorganization. Legislation includes H.R.3186 and S.1706, Smuggled Tobacco Prevention Act; H.R.3382, Smoke-Free Federal Building Act; S.1403, IDEA Full Funding Act; and H.R.65: Candy Tobacco Tax Parity Act of 2011. Issues related to cigar regulation on H.R.5973. Issues relating to tobacco and trade, including the Trans-Pacific Partnership.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC); and (4) issues relating to NIH reorganization. Legislation includes H.R.3186 and S.1706, Smuggled Tobacco Prevention Act; H.R.3382, Smoke-Free Federal Building Act; S.1403, IDEA Full Funding Act; and H.R.65: Candy Tobacco Tax Parity Act of 2011. Issues related to cigar regulation on H.R.5973. Issues relating to tobacco and trade, including the Trans-Pacific Partnership.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.